Frontier Capital Management CO LLC Denali Therapeutics Inc. Transaction History

Frontier Capital Management CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$50.3 - $78.44 $389,422 - $607,282	-7,742 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$53.8 - $81.53 $3.78 Million - $5.72 Million	-70,191 Reduced 90.07%	7,742 $442,000
Q4 2020 Jan 19, 2021	SELL	$36.89 - $93.56 $480,381 - $1.22 Million	-13,022 Reduced 14.32%	77,933 $6.53 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $2.1 Million - $3.53 Million	90,955 New	90,955 $3.26 Million

217

115M

142K

90.3K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.12B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.